Tetrapropylammonium

Tetrapropylammonium

SCHEMBL5874183

CCC[N+](CCC)(CCC)CCC.O=S(=O)(O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Tetrapropylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 4/20 0.62
TP53 P04637 2/20 0.41
SLC22A2 O15244 1/20 0.40
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
ALOX12 P18054 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
DNM1 Q05193 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrapropylammonium SCHEMBL330653 0.91 SLC22A1 (0.59) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Tetrapropylammonium SCHEMBL331329 0.91 SLC22A1 (0.59) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Tetrapropylammonium SCHEMBL622058 0.88 SLC22A1 (0.56) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Sulfuric Acid SCHEMBL11373725 0.88 SLC22A1 (0.47) SLC22A1TP53SLC22A2CA5ACA5B
Sulfuric Acid SCHEMBL15561064 0.87 SLC22A1 (0.62) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Sulfuric Acid SCHEMBL7638077 0.87 SLC22A1 (0.57) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Tetrapropylammonium SCHEMBL331022 0.84 SLC22A1 (0.50) SLC22A1TP53SLC22A2
Tetrabuthylammonium SCHEMBL27990806 0.82 SLC22A1 (0.67) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Tetrapentylammonium SCHEMBL10945546 0.82 SLC22A1 (0.67) SLC22A1TP53SLC22A2ALDH1A1CYP3A4
Tetrabuthylammonium SCHEMBL243899 0.82 SLC22A1 (0.67) SLC22A1TP53SLC22A2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
CN-108123161-B Colloid electrolyte of vanadium battery and vanadium battery 长沙无道工业设计有限公司 2020-10-30 CN claimed
CN-108123161-A The colloidal electrolyte and vanadium cell of a kind of vanadium cell 长沙无道工业设计有限公司 2018-06-05 CN claimed
CN-102005583-B Gelled electrolyte of vanadium battery and vanadium battery BYD CO LTD 2013-03-20 CN claimed
CN-102005583-A Gelled electrolyte of vanadium battery and vanadium battery BYD CO LTD 2011-04-06 CN claimed
US-4104141-A Electrochemical oxidation of alkoxy-substituted aromatic compounds UOP INC. (US) 1978-08-01 US claimed
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US disclosed
US-12319815-B2 Resin composition, method for producing same, and multi-liquid curable resin composition KANEKA CORPORATION (JP) 2025-06-03 US disclosed
US-12312494-B2 Resin composition, method for producing same, and multi-liquid curable resin composition KANEKA CORPORATION (JP) 2025-05-27 US disclosed
CN-112041970-B Aqueous composition and cleaning method using same 三菱瓦斯化学株式会社 2025-02-07 CN disclosed
US-20240002241-A1 VERTICALLY INTEGRATED MANUFACTURING OF SILICA AEROGELS FROM VARIOUS SILICA SOURCES AEROBEL BV (BE) 2024-01-04 US disclosed
CN-115003759-B Resin composition, method for producing same, and multicomponent curable resin composition 株式会社钟化 2023-12-01 CN disclosed
CN-116917368-A Curable resin composition and use thereof 株式会社钟化 2023-10-20 CN disclosed
CN-107001583-A Photocurable and thermosetting resin composition, cured product, and laminate 株式会社钟化 2017-08-01 CN disclosed
US-20170204226-A1 METHOD FOR PRODUCING SILOXANE RESIN KANEKA CORPORATION (JP) 2017-07-20 US disclosed
CN-102005583-B Gelled electrolyte of vanadium battery and vanadium battery BYD CO LTD 2013-03-20 CN disclosed
CN-102005583-A Gelled electrolyte of vanadium battery and vanadium battery BYD CO LTD 2011-04-06 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
US-4414079-A QUATERNARY AMMONIUM OR PHOSPHANIUM PHASE TRANSFER CATALYST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1983-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 SLC22A1 2747/4885TP53 3589/4885SLC22A2 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.